Viewing nowGlupio 15 mg Tablet (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Farmgen Science Co., Ltd.

MFDS item code 202003902 · Approved 2020.05.27 · Insurance code 670105240
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used as an adjunct to improve blood sugar control in patients with Type 2 diabetes. Patients are advised to take this medication along with dietary and exercise therapies for maximum effectiveness. Although it can be used as monotherapy, it may be combined with sulfonylureas, metformin, or insulin if blood sugar is not adequately controlled with other hypoglycemic agents. Additionally, nutritional counseling and weight loss are also important treatment elements and should be maintained alongside regular exercise. This comprehensive management helps in blood sugar control and supports the efficacy of the medication. Therefore, this medication is effectively used for blood sugar management in patients with Type 2 diabetes.
This medicine is administered orally once daily, regardless of meals. As monotherapy, treatment is initiated at 15 mg once daily and, if the effect is inadequate, the dose may be increased to 30 mg once daily. When administered in combination with a sulfonylurea, metformin, or insulin, the initial dose is also 15 mg once daily, and the maximum recommended dose should not exceed 30 mg once daily.
Use is not recommended in children under 18 years of age because there is no experience with its use.
This medication is primarily used for blood sugar control in patients with Type 2 diabetes. This medication may affect heart function, so it should not be used in patients with congestive heart failure or those with a history of heart failure. During treatment, careful monitoring for signs of fluid retention, such as swelling, sudden weight gain, or difficulty breathing, should be performed. If any heart failure symptoms occur, consult a doctor immediately for appropriate treatment, which may include reducing or discontinuing the dose of this medication if necessary. This medication requires the presence of insulin to exert its blood sugar-lowering effects and is not suitable for patients with Type 1 diabetes or diabetic ketoacidosis. It should also not be administered to patients with severely impaired liver function, severe renal impairment, active or past bladder cancer, pregnant women or females who may become pregnant. This medication may cause weight gain and fluid retention, and there may be an increased risk of fractures in women, so caution is required. The risk of hypoglycemia exists, particularly when combined with insulin or sulfonylureas, so symptoms of hypoglycemia should be closely monitored, and the doses of concomitant medications should be adjusted as needed. Regular monitoring of blood sugar levels and liver function tests is necessary during treatment, and any symptoms suggestive of liver damage (fatigue, loss of appetite, jaundice, etc.) should be reported to a physician immediately. Pre-menopausal women should use appropriate contraceptive methods, as ovulation may be stimulated while taking this medication. This medication may interact with other drugs, so patients should inform their physicians or pharmacists about any other medications they are taking. Finally, it is advisable not to use this medication in children or individuals under 18 due to lack of established safety and efficacy.
Congestive heart failure, excessive and rapid weight change, shortness of breath, edema, fluid retention, inadequate blood sugar control, upper respiratory infection, headache, sinusitis, myalgia, pharyngitis, abdominal distension, weight gain, hypoglycemia, urinary tract infection, low back pain, dizziness, diarrhea, elevated blood creatine kinase, hypertension, heart failure, limb pain, chest pain, death due to cardiovascular events, hospitalization due to worsening congestive heart failure, emergency room visit due to congestive heart failure, cardiovascular abnormalities, hepatic failure, diabetic macular edema accompanied by vision reduction, elevated serum ALT levels, decreased hemoglobin, increased plasma volume, elevated serum creatine kinase, bladder cancer, fracture, dizziness, loss of appetite, constipation, upper abdominal pain, chest pain, fatigue, weakness, dyspepsia, nausea, shortness of breath, itching, chest discomfort, tremors, chills, gastrointestinal disorders, abdominal pain, epigastric discomfort, numbness, muscle stiffness, head discomfort, increased liver enzymes, worsening liver disease, hives, eczema, joint pain, knee abnormalities, arm weakness, proteinuria, increased blood creatinine, anxiety, insomnia, drowsiness, simple herpes, blurred vision, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, heart function loss
Not everyone experiences these, and they can vary from person to person.
This medication should be protected from light and moisture and stored at a temperature between 15°C and 30°C. It is best stored in a cool place, approximately 25°C.
White, round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Farmgen Science Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.